Skip to content
TCR-T CELL THERAPY
OUR APPROACH
OUR SCIENCE
Manufacturing
PIPELINE
Clincal Trials
PATIENTS
PARTNERING
CONTROLLED IL-12
CAR-T THERAPIES
ABOUT
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PARTNERSHIPS
SCIENTIFIC PUBLICATIONS
CAREERS
Houston
CONTACT
INVESTORS
INVESTORS HOME
PRESS RELEASES
STOCK PERFORMANCE
Stock Information
Historic Lookup
SEC FILINGS
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
Board of Directors
Committees and Charters
ANALYST COVERAGE
INVESTOR FAQS
Menu
TCR-T CELL THERAPY
OUR APPROACH
OUR SCIENCE
Manufacturing
PIPELINE
Clincal Trials
PATIENTS
PARTNERING
CONTROLLED IL-12
CAR-T THERAPIES
ABOUT
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PARTNERSHIPS
SCIENTIFIC PUBLICATIONS
CAREERS
Houston
CONTACT
INVESTORS
INVESTORS HOME
PRESS RELEASES
STOCK PERFORMANCE
Stock Information
Historic Lookup
SEC FILINGS
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
Board of Directors
Committees and Charters
ANALYST COVERAGE
INVESTOR FAQS
Pipeline
An Advanced Platform Targeting Solid Tumors
Focused Pipeline of Innovation in Cell Therapy for Oncology
